UBS analyst Patrick Rafaisz upgraded EMS-Chemie (EMSHF) to Buy from Neutral with a price target of CHF 720, up from CHF 670. With shares trading near six year lows and almost 50% off their 2021/22 peak with EPS in CHF flat over the same period, the firm says the “chemistry is finally right” and expresses confidence that “the worst is now behind.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMSHF: